United Capital Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.2M | Sell |
144,688
-26,123
| -15% | -$3.66M | 0.12% | 142 |
|
|
2025
Q4 | $21M | Sell |
170,811
-6,785
| -4% | -$825K | 0.13% | 144 |
|
|
2025
Q3 | $19.7M | Sell |
177,596
-3,695
| -2% | -$420K | 0.14% | 130 |
|
|
2025
Q2 | $20.1M | Sell |
181,291
-7,743
| -4% | -$824K | 0.16% | 117 |
|
|
2025
Q1 | $21.2M | Sell |
189,034
-14,227
| -7% | -$1.47M | 0.18% | 109 |
|
|
2024
Q4 | $18.8M | Sell |
203,261
-43,103
| -17% | -$3.88M | 0.16% | 116 |
|
|
2024
Q3 | $20.7M | Sell |
246,364
-7,802
| -3% | -$595K | 0.17% | 118 |
|
|
2024
Q2 | $17.4M | Sell |
254,166
-10,921
| -4% | -$729K | 0.15% | 131 |
|
|
2024
Q1 | $19.4M | Sell |
265,087
-38,317
| -13% | -$2.95M | 0.16% | 127 |
|
|
2023
Q4 | $24.6M | Sell |
303,404
-303,600
| -50% | -$23.6M | 0.2% | 106 |
|
|
2023
Q3 | $45.5M | Sell |
607,004
-44,680
| -7% | -$3.44M | 0.3% | 72 |
|
|
2023
Q2 | $50.2M | Sell |
651,684
-28,805
| -4% | -$2.3M | 0.27% | 74 |
|
|
2023
Q1 | $56.5M | Sell |
680,489
-13,365
| -2% | -$1.11M | 0.32% | 64 |
|
|
2022
Q4 | $59.6M | Sell |
693,854
-19,762
| -3% | -$1.56M | 0.33% | 65 |
|
|
2022
Q3 | $44M | Buy |
713,616
+6,377
| +0.9% | +$402K | 0.26% | 78 |
|
|
2022
Q2 | $43.7M | Buy |
707,239
+482
| +0.1% | +$29.8K | 0.24% | 84 |
|
|
2022
Q1 | $42M | Buy |
706,757
+10,732
| +2% | +$686K | 0.2% | 102 |
|
|
2021
Q4 | $50.5M | Buy |
696,025
+27,354
| +4% | +$1.88M | 0.23% | 90 |
|
|
2021
Q3 | $46.7M | Buy |
668,671
+18,941
| +3% | +$1.33M | 0.23% | 87 |
|
|
2021
Q2 | $44.7M | Buy |
649,730
+34,314
| +6% | +$2.29M | 0.23% | 91 |
|
|
2021
Q1 | $39.8M | Buy |
615,416
+26,645
| +5% | +$1.72M | 0.22% | 100 |
|
|
2020
Q4 | $34.3M | Buy |
588,771
+50,106
| +9% | +$3.02M | 0.21% | 104 |
|
|
2020
Q3 | $34M | Buy |
538,665
+51,870
| +11% | +$3.6M | 0.22% | 104 |
|
|
2020
Q2 | $37.5M | Buy |
486,795
+32,289
| +7% | +$2.47M | 0.27% | 82 |
|
|
2020
Q1 | $33.6M | Sell |
454,506
-33,013
| -7% | -$2.28M | 0.28% | 78 |
|
|
2019
Q4 | $31.7M | Buy |
487,519
+44,993
| +10% | +$2.93M | 0.2% | 107 |
|
|
2019
Q3 | $28M | Buy |
442,526
+23,544
| +6% | +$1.54M | 0.2% | 115 |
|
|
2019
Q2 | $28.3M | Buy |
418,982
+33,072
| +9% | +$2.18M | 0.19% | 117 |
|
|
2019
Q1 | $25.1M | Buy |
385,910
+152,733
| +66% | +$10.2M | 0.18% | 124 |
|
|
2018
Q4 | $14.6M | Sell |
233,177
-12,903
| -5% | -$902K | 0.12% | 183 |
|
|
2018
Q3 | $19M | Sell |
246,080
-314,379
| -56% | -$23.7M | 0.13% | 165 |
|
|
2018
Q2 | $39.7M | Buy |
560,459
+338,290
| +152% | +$23.9M | 0.3% | 72 |
|
|
2018
Q1 | $16.6M | Sell |
222,169
-141,083
| -39% | -$11.2M | 0.13% | 183 |
|
|
2017
Q4 | $26.3M | Buy |
363,252
+28,674
| +9% | +$2.18M | 0.21% | 111 |
|
|
2017
Q3 | $27.1M | Buy |
334,578
+14,643
| +5% | +$1.12M | 0.23% | 104 |
|
|
2017
Q2 | $22.6M | Sell |
319,935
-16,118
| -5% | -$1.07M | 0.2% | 113 |
|
|
2017
Q1 | $22.8M | Buy |
336,053
+101,532
| +43% | +$7.14M | 0.21% | 104 |
|
|
2016
Q4 | $16.8M | Sell |
234,521
-9,814
| -4% | -$729K | 0.16% | 139 |
|
|
2016
Q3 | $19.3M | Buy |
244,335
+18,578
| +8% | +$1.51M | 0.19% | 123 |
|
|
2016
Q2 | $18.7M | Buy |
225,757
+4,124
| +2% | +$366K | 0.19% | 114 |
|
|
2016
Q1 | $20.4M | Buy |
221,633
+11,644
| +6% | +$1.05M | 0.22% | 87 |
|
|
2015
Q4 | $21.2M | Buy |
209,989
+4,042
| +2% | +$421K | 0.24% | 84 |
|
|
2015
Q3 | $20.2M | Buy |
205,947
+22,080
| +12% | +$2.45M | 0.24% | 77 |
|
|
2015
Q2 | $21.5M | Buy |
183,867
+793
| +0.4% | +$86.7K | 0.25% | 95 |
|
|
2015
Q1 | $18.4M | Buy |
183,074
+34,745
| +23% | +$3.53M | 0.22% | 109 |
|
|
2014
Q4 | $14M | Buy |
148,329
+46,528
| +46% | +$4.81M | 0.21% | 118 |
|
|
2014
Q3 | $10.8M | Sell |
101,801
-7,550
| -7% | -$739K | 0.19% | 137 |
|
|
2014
Q2 | $9.07M | Buy |
109,351
+33,640
| +44% | +$2.62M | 0.17% | 160 |
|
|
2014
Q1 | $5.37M | Buy |
+75,711
| New | +$5.94M | 0.11% | 202 |
|
|
2013
Q4 | – | Sell |
-3,432
| Closed | -$216K | – | 691 |
|
|
2013
Q3 | $216K | Buy |
+3,432
| New | +$205K | 0.01% | 619 |
|
Other funds holding GILD
VCM
VPM
United Capital Financial Advisors's GILD Position: Q1 2026 in Review
United Capital Financial Advisors reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $3.66M and leaving 144,688 shares worth $20.2M. The position accounts for 0.12% of the portfolio, ranked #142.
United Capital Financial Advisors first reported a position in GILD in Q3 2013 and has held it in 50 quarters since. The position peaked at $59.6M in Q4 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- United Capital Financial Advisors held 144,688 shares of Gilead Sciences worth $20.2M as of Q1 2026.
- United Capital Financial Advisors sold 26,123 Gilead Sciences shares in Q1 2026, an estimated $3.66M.
- Gilead Sciences made up 0.12% of United Capital Financial Advisors's portfolio in Q1 2026, its #142 holding.
- United Capital Financial Advisors first reported a position in Gilead Sciences in Q3 2013 and has held it in 50 quarters since.
- United Capital Financial Advisors's Gilead Sciences position peaked at $59.6M in Q4 2022.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.